Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:01 pm Purchase | 2023-12-31 | 13G | Verastem, Inc. VSTM | Vivo Opportunity LLC | 1,538,461 6.100% | 1,538,461 (New Position) | Filing History |
| 2024-02-13 5:00 pm Purchase | 2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Vivo Opportunity LLC | 2,482,727 4.500% | 801,528 (+47.68%) | Filing History |
| 2023-02-13 5:49 pm Purchase | 2022-12-31 | 13G | Geron Corporation GERN | Vivo Opportunity LLC | 26,901,882 4.300% | 4,044,739 (+17.70%) | Filing History |
| 2023-02-13 5:45 pm Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Vivo Opportunity LLC | 1,678,207 4.200% | 378,207 (+29.09%) | Filing History |
| 2023-02-13 5:42 pm Sale | 2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Vivo Opportunity LLC | 2,251,663 3.600% | -149,613 (-6.23%) | Filing History |
| 2023-02-13 5:40 pm Purchase | 2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Vivo Opportunity LLC | 1,681,199 6.800% | 681,199 (+68.12%) | Filing History |
| 2022-09-08 4:00 pm Purchase | 2022-08-31 | 13G | Astria Therapeutics, Inc. ATXS | Vivo Opportunity LLC | 1,000,000 7.100% | 1,000,000 (New Position) | Filing History |
| 2022-04-08 4:00 pm Purchase | 2022-04-01 | 13G | Geron Corporation GERN | Vivo Opportunity LLC | 22,857,143 5.900% | 22,857,143 (New Position) | Filing History |
| 2022-02-11 5:21 pm Sale | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Vivo Opportunity LLC | 2,401,276 4.100% | -481,548 (-16.70%) | Filing History |
| 2021-09-30 4:30 pm Purchase | 2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN | Vivo Opportunity LLC | 1,300,000 7.700% | 1,300,000 (New Position) | Filing History |
| 2021-02-12 4:30 pm Sale | 2020-12-31 | 13G | Genocea Biosciences, Inc. GNCA | Vivo Opportunity LLC | 613,437 1.200% | -830,401 (-57.51%) | Filing History |
| 2021-02-12 4:30 pm Sale | 2020-12-31 | 13G | Verastem, Inc. VSTM | Vivo Opportunity LLC | 0 0.000% | -554,553 (Position Closed) | Filing History |
| 2021-02-12 4:30 pm Sale | 2020-12-31 | 13G | MEI Pharma, Inc. MEIP | Vivo Opportunity LLC | 165,017 2.800% | -368,606 (-69.08%) | Filing History |